Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00230906
Other study ID # 2001/182
Secondary ID
Status Completed
Phase N/A
First received September 29, 2005
Last updated December 19, 2007
Start date January 2001
Est. completion date April 2002

Study information

Verified date December 2007
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority Belgium: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane


Description:

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date April 2002
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Chronic haemodialysis patient

- Serum albumin > 3.6 g/dl

Exclusion Criteria:

- < 18 years

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Haemodialysis with either low or high flux membranes


Locations

Country Name City State
Belgium University Hospital Ghent Ghent

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Ghent Nissho Nipro Europe

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concentration of uremic components after 3 weeks of haemodialysis
See also
  Status Clinical Trial Phase
Completed NCT01224314 - Potassium in Haemodialysis Fluids and Haemodynamics N/A
Not yet recruiting NCT05525234 - A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus Phase 4
Active, not recruiting NCT04139525 - Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With MCO PES-PVP (Theranova) Membrane N/A
Completed NCT02887742 - Epidemiologic Study and Impact Study of a Dialysis Solution Change on the Electrocardiographic Profile of Patient N/A
Completed NCT01163981 - Ultrasound Guided Cannulation of Dialysis Fistulas N/A
Recruiting NCT02902848 - Evaluation of the Validity of the Prothrombin Time Internation Normalised Ratio (PT/INR) Measured at the point-of Care on the Arterial Bloodline of Haemodialysis Extracorporeal Blood Flow N/A
Completed NCT00718289 - Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes Phase 4
Not yet recruiting NCT06225544 - Lumasiran in Hyperoxalaemic Patients on Haemodialysis Phase 2
Completed NCT02707757 - Treatment Response in Dialysis Anaemia Phase 4
Terminated NCT01382888 - Efficacy and Local Tolerability of Topically Applied Heparin on the Suitability of Newly Constructed Primary Arteriovenous Fistulas in Patients Planned for Haemodialysis Phase 2
Recruiting NCT00829153 - U Clip Study - Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis Phase 1/Phase 2
Not yet recruiting NCT05128188 - SASH: Sodium Accumulation Study In Haemodialysis
Completed NCT05729997 - Live Classical Music and the Response to the Disease and Its Evolution in Patients With Chronic Renal Failure N/A
Active, not recruiting NCT02063776 - Haemodiafiltration vs Conventional Haemodialysis in Children N/A
Completed NCT05280106 - Citrate Dialysate in Online Hemodialfiltration N/A
Recruiting NCT04842591 - Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation
Not yet recruiting NCT06112262 - Comparison Between Haparin and Herodin in HD Early Phase 1
Recruiting NCT04260412 - The Effect of Combining Medium Cut Off Dialysis Membrane and Diet Modification on Reducing of Inflammation Response N/A
Recruiting NCT04247867 - Combination of Medium Cut-off Dialyzer Membrane and Diet Modification to Alleviate Residual Uremic Syndrome of Dialysis Patients N/A
Completed NCT00388661 - Melatonin and Quality of Life in Dialysis Patients Phase 3